PURE Teams Up with Swabplus to Tackle China
Shares of PURE Bioscience (OTCBB: PURE) jumped up today after news about its distribution agreement with Swabplus came out earlier this morning. In early trading today, PURE was up 17 cents (5 percent) to $3.47 per share. PURE announced in a press release that it has granted a license to market and sell its patented silver dihydrogen citrate (SDC)-based hard surface disinfectant in China, Hong Kong and Taiwan to privately held Swabplus Inc. "We are excited about the opportunity to introduce SDC into Asia as a more effective alternative to traditional poisonous disinfectants and a powerful weapon against dangerous pathogens…